{
  "Symbol": "ZTS",
  "AssetType": "Common Stock",
  "Name": "Zoetis Inc",
  "Description": "Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.",
  "CIK": "1555280",
  "Exchange": "NYSE",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "LIFE SCIENCES",
  "Industry": "PHARMACEUTICAL PREPARATIONS",
  "Address": "10 SYLVAN WAY, PARSIPPANY, NJ, US",
  "OfficialSite": "https://www.zoetis.com",
  "FiscalYearEnd": "December",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "66904691000",
  "EBITDA": "3829000000",
  "PERatio": "27.42",
  "PEGRatio": "2.595",
  "BookValue": "10.64",
  "DividendPerShare": "1.728",
  "DividendYield": "0.0133",
  "EPS": "5.47",
  "RevenuePerShareTTM": "20.38",
  "ProfitMargin": "0.269",
  "OperatingMarginTTM": "0.331",
  "ReturnOnAssetsTTM": "0.149",
  "ReturnOnEquityTTM": "0.511",
  "RevenueTTM": "9255999000",
  "GrossProfitTTM": "6538000000",
  "DilutedEPSTTM": "5.47",
  "QuarterlyEarningsGrowthYOY": "0.132",
  "QuarterlyRevenueGrowthYOY": "0.047",
  "AnalystTargetPrice": "198.31",
  "AnalystRatingStrongBuy": "4",
  "AnalystRatingBuy": "10",
  "AnalystRatingHold": "5",
  "AnalystRatingSell": "0",
  "AnalystRatingStrongSell": "0",
  "TrailingPE": "27.42",
  "ForwardPE": "24.39",
  "PriceToSalesRatioTTM": "7.23",
  "PriceToBookRatio": "13.73",
  "EVToRevenue": "7.59",
  "EVToEBITDA": "18.23",
  "Beta": "0.925",
  "52WeekHigh": "198.58",
  "52WeekLow": "139.22",
  "50DayMovingAverage": "160.82",
  "200DayMovingAverage": "174.83",
  "SharesOutstanding": "446061000",
  "DividendDate": "2025-06-03",
  "ExDividendDate": "2025-04-21",
  "Last Updated": "2025-04-23 14:46:07",
  "Price_Day_1": 149.99,
  "Price_Day_2": 146.85,
  "Price_Day_3": 148.16552086868,
  "Price_Day_4": 146.262002035969,
  "Price_Day_5": 148.713654563963,
  "Price_Day_6": 150.318191381065,
  "Price_Day_7": 148.932908042077,
  "Income_totalRevenue_Q1": "2317000000",
  "Income_grossProfit_Q1": "1610000000",
  "Income_netIncome_Q1": "581000000",
  "Income_totalRevenue_Q2": "2388000000",
  "Income_grossProfit_Q2": "1687000000",
  "Income_netIncome_Q2": "682000000",
  "Income_totalRevenue_Q3": "2361000000",
  "Income_grossProfit_Q3": "1658000000",
  "Income_netIncome_Q3": "624000000",
  "Income_totalRevenue_Q4": "2190000000",
  "Income_grossProfit_Q4": "1510000000",
  "Income_netIncome_Q4": "599000000",
  "Balance_totalAssets_Q1": "14237000000",
  "Balance_totalLiabilities_Q1": "9467000000",
  "Balance_totalShareholderEquity_Q1": "4770000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "1985000000",
  "Balance_totalAssets_Q2": "14357000000",
  "Balance_totalLiabilities_Q2": "9123000000",
  "Balance_totalShareholderEquity_Q2": "5234000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "1710000000",
  "Balance_totalAssets_Q3": "14165000000",
  "Balance_totalLiabilities_Q3": "9205000000",
  "Balance_totalShareholderEquity_Q3": "4966000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "1573000000",
  "Balance_totalAssets_Q4": "14348000000",
  "Balance_totalLiabilities_Q4": "9296000000",
  "Balance_totalShareholderEquity_Q4": "5058000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "1973000000",
  "Debt to Equity Ratio": 1.98,
  "Is Complete": true
}